Document Detail


Investigations into the mechanisms of coronary vasodilation by contrast media in dogs.
MedLine Citation:
PMID:  8877492     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
RATIONALE AND OBJECTIVES: The study was performed to clarify the mechanisms underlying contrast-induced coronary vasodilation. METHODS: The left anterior descending coronary artery of 14 open-chest dogs was perfused at constant pressure. Coronary blood flow (CBF) was measured electromagnetically and used to calculate myocardial oxygen consumption (MVO2). Responses were evaluated during intracoronary infusions (2 mL/ minute) of the ionic contrast medium, Hypaque-76, and the nonionic contrast medium, Isovue-370, and compared with those caused by hypertonic saline solutions with comparable osmolarities. Studies also were conducted using Isovist-300, which is a new nonionic and iso-osmolar contrast medium. RESULTS: Hypaque-76 and Isovue-370 caused initial peak increases in CBF (reflecting decreases in coronary vascular resistance), which waned rapidly to achieve more modest steady-state increases within 2 to 3 minutes. Both the peak and steady-state increases in CBF were greater during Hypaque-76 than during Isovue-370. The increases in CBF caused by the contrast medium were greater than those caused by the corresponding saline solution. Neither Hypaque-76 nor Isovue-370 changed MVO2-Isovist-300 had no effect on CBF or MVO2. CONCLUSIONS: The coronary vasodilation by contrast media is the result of a direct vasorelaxing effect rather than secondary to a metabolic mechanism. Hyperosmolarity can account only in part for contrast-induced coronary vasodilation.
Authors:
G J Crystal; M R Salem
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Investigative radiology     Volume:  31     ISSN:  0020-9996     ISO Abbreviation:  Invest Radiol     Publication Date:  1996 Sep 
Date Detail:
Created Date:  1997-01-17     Completed Date:  1997-01-17     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0045377     Medline TA:  Invest Radiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  556-62     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology, Illinois Masonic Medical Center, University of Illinois College of Medicine 60657, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Contrast Media / pharmacology*
Coronary Circulation / drug effects
Coronary Vessels / drug effects*
Diatrizoate / pharmacology
Diatrizoate Meglumine / pharmacology
Dogs
Drug Combinations
Female
Iopamidol / pharmacology
Male
Myocardium / metabolism
Osmolar Concentration
Oxygen Consumption
Saline Solution, Hypertonic / pharmacology
Triiodobenzoic Acids / pharmacology
Vasodilation / drug effects*
Grant Support
ID/Acronym/Agency:
HL-47629/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Drug Combinations; 0/Saline Solution, Hypertonic; 0/Triiodobenzoic Acids; 117-96-4/Diatrizoate; 131-49-7/Diatrizoate Meglumine; 62883-00-5/Iopamidol; 79770-24-4/iotrolan; 8064-12-8/urovision

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An experimental study on the neurotolerability of gadobenate dimeglumine in a rat model of focal bra...
Next Document:  Robustness of computerized identification of masses in digitized mammograms. A preliminary assessmen...